E-ISSN: 2349-9036 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access
Research & Reviews: A Journal of Drug Design & Discovery Research & Reviews: A Journal of Drug Design & Discovery [2349-9036(e)]Â is a peer-reviewed hybrid open access journal launched in 2014 covers the latest research on how drugs work, rational approaches such as Structure-based drug design, …
rrjoddd maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Dr. Sidhartha Sankar Kar, Professor & HOD
School of Pharmacy, DRIEMS University, Cuttack, Odisha, India, 754022
Email :
Institutional Profile Link: https://www.driems.ac.in/faculty/school-of-pharmacy-faculty/dr-sidhartha-sankar-kar-2/
Journal: Research & Reviews: A Journal of Drug Design & Discovery
RNA-based therapeutics have emerged as a transformative approach in modern medicine due to their ability to regulate gene expression with high specificity and precision.
Long-acting injectable (LAI) formulations represent a transformative approach in pharmacotherapy, particularly for conditions demanding sustained drug exposure over weeks to months.
The dengue virus causes serious health issues and a loss of quality of life. Dengue poses a yearly threat to half of the world’s population.
Inflammation diseases still threaten humanity everywhere. For which there is always a continuous demand for immediate medication, the so-called anti-inflammatory drug.
The process of finding new leads for medicines using natural products is challenging. It discusses bioactive composites generated from natural resources, including phytochemical analysis, characterization, and pharmacological investigation.
Multidrug-resistant TB is a growing worldwide health concern, particularly in high-burden areas. Resistance to frontline drugs like isoniazid and rifampicin is caused by mutations in key Mycobacterium tuberculosis proteins.
